{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:07:35Z","timestamp":1792098455832,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40123-016-0067-1","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T04:58:49Z","timestamp":1476507529000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Uveitis Specialists and Rheumatologists Select Different Therapies for Idiopathic Non-necrotizing Anterior Scleritis"],"prefix":"10.1007","volume":"5","author":[{"given":"Daniel J.","family":"Ozzello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Kolfenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Palestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,15]]},"reference":[{"issue":"12","key":"67_CR1","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/ICO.0b013e3182a407c3","volume":"32","author":"G Honik","year":"2013","unstructured":"Honik G, Wong IG, Gritz DC. Incidence and prevalence of episcleritis and scleritis in Northern California. Cornea. 2013;32(12):1562\u20136.","journal-title":"Cornea"},{"issue":"1","key":"67_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09273948.2015.1005240","volume":"24","author":"A Lavric","year":"2016","unstructured":"Lavric A, Gonzalez-Lopez JJ, Majumder PD, et al. Posterior scleritis: analysis of epidemiology, clinical factors, and risk of recurrence in a cohort of 114 patients. Ocul Immunol Inflamm. 2016;24(1):6\u201315.","journal-title":"Ocul Immunol Inflamm."},{"key":"67_CR3","doi-asserted-by":"crossref","unstructured":"Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Scleritis therapy. Ophthalmology. 2012;119(1):51\u201358.","DOI":"10.1016\/j.ophtha.2011.07.043"},{"key":"67_CR4","first-page":"76","volume":"94","author":"PG Watson","year":"1974","unstructured":"Watson PG. Treatment of scleritis and episcleritis. Trans Ophthal Soc UK. 1974;94:76\u20139.","journal-title":"Trans Ophthal Soc UK"},{"issue":"4","key":"67_CR5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130(4):469\u201376.","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"67_CR6","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0161-6420(03)00570-0","volume":"110","author":"HN Sen","year":"2003","unstructured":"Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR. Mycophenolate mofetil for the treatment of scleritis. Ophthalmology. 2003;110(9):1750\u20135.","journal-title":"Ophthalmology"},{"issue":"8","key":"67_CR7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","volume":"112","author":"JE Thorne","year":"2005","unstructured":"Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology. 2005;112(8):1472\u20137.","journal-title":"Ophthalmology"},{"issue":"3","key":"67_CR8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajo.2007.11.010","volume":"145","author":"AW Jachens","year":"2008","unstructured":"Jachens AW, Chu DS. Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis. Am J Ophthalmol. 2008;145(3):487\u201392.","journal-title":"Am J Ophthalmol"},{"key":"67_CR9","doi-asserted-by":"crossref","unstructured":"Ozzello DJ, Palestine AG. Factors affecting therapeutic decisions in intermediate and posterior uveitis. Am J Ophthalmol. 2015;159(2):213\u2013220.e213.","DOI":"10.1016\/j.ajo.2014.10.015"},{"key":"67_CR10","doi-asserted-by":"crossref","unstructured":"Palestine AG, Kolfenbach JR, Ozzello DJ. Rheumatologists and ophthalmologists differ in treatment decisions for ocular Behcet disease. J Clin Rheumatol. 2016;22(6):316\u20139.","DOI":"10.1097\/RHU.0000000000000424"},{"issue":"4","key":"67_CR11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3928\/01913913-20160505-01","volume":"53","author":"DJ Ozzello","year":"2016","unstructured":"Ozzello DJ, Singh J, Kolfenbach JR, Palestine AG. Specialty practice and cost considerations in the management of juvenile idiopathic arthritis-associated uveitis. J Pediatr Ophthalmol Strabismus. 2016;53(4):246\u201351.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"10","key":"67_CR12","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ophtha.2014.04.023","volume":"121","author":"SR Rathinam","year":"2014","unstructured":"Rathinam SR, Babu M, Thundikandy R, et al. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014;121(10):1863\u201370.","journal-title":"Ophthalmology"},{"key":"67_CR13","doi-asserted-by":"crossref","unstructured":"Jabs DA. Subconjunctival corticosteroids should not be used in the treatment of scleritis (discussion). Ophthalmology. 2002;109:806\u20137.","DOI":"10.1016\/S0161-6420(01)01020-X"},{"key":"67_CR14","doi-asserted-by":"crossref","unstructured":"Johnson KS, Chu DS. Evaluation of sub-Tenon triamcinolone acetonide injections in the treatment of scleritis. Am J Ophthalmol. 2010;149(1):77\u201381.","DOI":"10.1016\/j.ajo.2009.07.035"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-016-0067-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T16:38:52Z","timestamp":1568479132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40123-016-0067-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,15]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1007\/s40123-016-0067-1","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,15]]}}}